Company Profile

Monterey Innovation Acquisition Corp., formerly Monterey Bio Acquisition Corp., is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its efforts on identifying a disruptive technology company.

Employees

Sector

Investment Holding Companies

More about the company

20/11/23	Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index	CI
22/08/23	Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
19/05/23	Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
17/04/23	Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
17/04/23	Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
11/03/23	Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition	MT
11/03/23	Monterey Bio Acquisition Corporation Announces Board Changes	CI
11/03/23	Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer	CI
11/03/23	Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer	CI
11/11/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
07/10/22	Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC	CI
12/08/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
14/05/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI

17/04/23	MONTEREY INNOVATION ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
11/03/23	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/11/22	MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
12/10/22	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
01/10/22	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ

Manager	Title	Age	Since
Murat Omur CEO	Chief Executive Officer	48	09/03/2023
David Smith PRN	Corporate Officer/Principal	66	-
Sanjeev Satyal CEO	Chief Executive Officer	57	01/04/2021

Director	Title	Age	Since
Jonas Grossman CHM	Chairman	52	09/03/2023
Frances K. Heller BRD	Director/Board Member	59	30/09/2021
James Neal CHM	Chairman	70	30/09/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/3/23	Jonas Grossman	Sell	Chairman	491,250	10.0370%
9/3/23	Sandip I. Patel	Sell	Director	645,000	13.1784%
9/3/23	Sanjeev Satyal	Others	Executive/Senior Manager	75,000	1.5324%

Monterey Innovation Acquisition Corp. Stock

Stocks

MTRY

US61240F1084

Investment Holding Companies

Latest news : Monterey Innovation Acquisition Corp.

Press Releases : Monterey Innovation Acquisition Corp.

Quotes and Performance

Managers and Directors : Monterey Innovation Acquisition Corp.

Latest insider transactions

Shell Companies

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MONTEREY INNOVATION ACQUISITION CORP.	-0.09%	-1.59%	-	-	48.3M
CHURCHILL CAPITAL CORP XI	-4.18%	-8.21%	-	-	714M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.07%	-0.07%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.63%	-0.24%	-	-	602M
CHURCHILL CAPITAL CORP XII	+0.46%	+0.65%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.43%	+1.87%	-	592M
CENTIEL AG	+1.75%	+8.99%	+276.46%	-78.44%	575M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.97%	-1.23%	-	-	563M
CHURCHILL CAPITAL CORP XIII	+0.76%	+0.66%	-	-	509M
Average	-0.37%	-0.26%	+139.16%	-78.44%	599.69M
Weighted average by Cap.	-0.50%	-0.46%	+137.21%	-78.44%